SCHEMBL2038853

SCHEMBL2038853

CC1(CNC(=O)CCl)CCCN1C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TGM2 P21980 1/20 0.30
EPHX1 P07099 1/20 0.30
EPHX2 P34913 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22341325 0.82 DPP4 (0.31)
SCHEMBL2054066 0.81 GRIN2B (0.35) SMN1; SMN2EPHX1
SCHEMBL338048 0.79 ALDH1A1 (0.30) ALDH1A1SMN1; SMN2
SCHEMBL337878 0.79 ALDH1A1 (0.30) ALDH1A1SMN1; SMN2
SCHEMBL22341282 0.77
SCHEMBL4256166 0.73 DPP4 (0.32)
SCHEMBL19947945 0.73 DPP4 (0.32)
SCHEMBL19947946 0.73 DPP4 (0.32)
SCHEMBL2041523 0.72 DPP4 (0.34) ALDH1A1SMN1; SMN2
SCHEMBL30067725 0.72 DPP4 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075699-A2 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2011-06-23 WO disclosed